老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

0.2320
-0.0459-16.52%
成交量：82.04万
成交额：19.22万
市值：310.05万
市盈率：-0.05
高：0.2769
开：0.2636
低：0.2000
收：0.2779
52周最高：11.00
52周最低：0.0002
股本：1,336.42万
流通股本：340.45万
量比：0.96
换手率：24.10%
股息：- -
股息率：- -
每股收益(TTM):-4.9510
每股收益(LYR):-14.8490
净资产收益率：-1236.83%
总资产收益率：-427.27%
市净率：0.22
市盈率(LYR):-0.02

数据加载中...

总览公司新闻资讯公告
2021/09/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/09/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/25

重要事件披露

8-K - Current report
2021/08/18

重要事件披露

8-K - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/19

重要事件披露

8-K - Current report
2021/02/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/11

重要事件披露

8-K - Current report
2020/12/30

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/03

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/13

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多